Who owns the C·RCLE trademark?

The C·RCLE trademark is owned by Innovus Pharmaceuticals, Inc..

What class is the C·RCLE trademark registered in?

The C·RCLE trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations).

What is the serial number for C·RCLE?

The USPTO serial number for C·RCLE is 99197885.

What is the registration number for C·RCLE?

C·RCLE is registered under USPTO registration number 8330907.

Sealvo

Home Search: C·RCLEC·RCLE #99197885

Back

Updated Oct 14, 2026·12 searches this week

View on USPTO TSDR Find similar marks

CRC

USPTO Trademark Record

REGISTERED

C·RCLE

SN 99197885·Reg 8330907·Filed May 22, 2025

Owner Innovus Pharmaceuticals, Inc.

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.

C·RCLE (Serial No. 99197885), Registration No. 8330907, is a registered US trademark filed on May 22, 2025 by Innovus Pharmaceuticals, Inc.. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations).

early section 8: July 07, 2032

Mark Intelligence

C·RCLE (Reg. #8330907) is a registered US trademark that has been protecting its owner, Innovus Pharmaceuticals, Inc., since 2025. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations). Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs.... The mark faced 1 opposition proceeding during prosecution.

FILED

May 22, 2025

SERIAL

99197885

REG#

8330907

REGISTERED

Jul 07, 2026

Filing Information

StatusREGISTERED

Filing DateMay 22, 2025

Serial Number99197885

Registration No.8330907

Registration DateJul 07, 2026

Status DateJul 07, 2026

Published for OppositionMay 19, 2026

Filing Basis & Declarations

Filed as Use ApplicationUse Application CurrentlyTrademark

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 005, 006, 018, 044, 046, 051, 052

First use anywhere: May 01, 2023

First use in commerce: May 01, 2023

This description is as filed with the USPTO and defines the scope of trademark protection.

Run a conflict check

Search by serial number, mark name, or logo. See conflicting marks ranked by risk with clear explanations of what contributed.

Run conflict check

Status History

24 events

REGISTERED-PRINCIPAL REGISTER

Jul 07, 2026

REGISTERED-PRINCIPAL REGISTER

NOTICE OF REGISTRATION CONFIRMATION EMAILED

Jul 07, 2026

NOTICE OF REGISTRATION CONFIRMATION EMAILED

PUBLISHED FOR OPPOSITION

May 19, 2026

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

May 19, 2026

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

May 13, 2026

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

APPROVED FOR PUB - PRINCIPAL REGISTER

Apr 21, 2026

APPROVED FOR PUB - PRINCIPAL REGISTER

EXAMINERS AMENDMENT -WRITTEN

Mar 31, 2026

EXAMINERS AMENDMENT -WRITTEN

EXAMINERS AMENDMENT E-MAILED

Mar 31, 2026

EXAMINERS AMENDMENT E-MAILED

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

Mar 31, 2026

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

EXAMINER'S AMENDMENT ENTERED

Mar 31, 2026

EXAMINER'S AMENDMENT ENTERED

NON-FINAL ACTION WRITTEN

Mar 02, 2026

NON-FINAL ACTION WRITTEN

NON-FINAL ACTION E-MAILED

Mar 02, 2026

NON-FINAL ACTION E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Mar 02, 2026

NOTIFICATION OF NON-FINAL ACTION E-MAILED

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Jan 28, 2026

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Jan 28, 2026

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

Jan 28, 2026

TEAS/EMAIL CORRESPONDENCE ENTERED

NON-FINAL ACTION WRITTEN

Nov 04, 2025

NON-FINAL ACTION WRITTEN

NON-FINAL ACTION E-MAILED

Nov 04, 2025

NON-FINAL ACTION E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Nov 04, 2025

NOTIFICATION OF NON-FINAL ACTION E-MAILED

ASSIGNED TO EXAMINER

Oct 23, 2025

ASSIGNED TO EXAMINER

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Oct 22, 2025

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

NOTICE OF DESIGN SEARCH CODE E-MAILED

Oct 22, 2025

NOTICE OF DESIGN SEARCH CODE E-MAILED

NEW APPLICATION ENTERED

May 22, 2025

NEW APPLICATION ENTERED

APPLICATION FILING RECEIPT MAILED

May 22, 2025

APPLICATION FILING RECEIPT MAILED

Other Marks by Innovus Pharmaceuticals, Inc.

Additional USPTO filings from the same owner.

REG

REGOXIDINE

88416815

Innovus Pharmaceuticals, Inc.

REGISTERED

OME

OMEPRACAREDR

98813842

Innovus Pharmaceuticals, Inc.

REGISTERED

FLU

FLUTICARE

87601188

Innovus Pharmaceuticals, Inc.

REGISTERED

OCT

OCTIQ

97470919

Innovus Pharmaceuticals, Inc.

REGISTERED

C·RCLE

Run a conflict check

Other Marks by Innovus Pharmaceuticals, Inc.

Get pre-filing clearance

Search 14M+ trademarks

Resources

Company